CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Five Prime Therapeutics Inc   (FPRX)
Other Ticker:  
 
 

FPRX's Net Income Growth by Quarter and Year

Five Prime Therapeutics Inc 's Net Income results by quarter and year




FPRX Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December -20.85 -31.36 -29.53 -29.21
III Quarter September -26.42 -36.07 -47.24 -43.28
II Quarter June -16.94 -34.39 -34.06 -44.29
I Quarter March -20.12 -35.39 -20.39 -33.44
FY   -84.33 -137.21 -131.22 -150.22



FPRX Net Income fourth quarter 2020 Y/Y Growth Comment
Five Prime Therapeutics Inc in the fourth quarter 2020 recorded net loss of $ -20.85 millions.

According to the results reported in the fourth quarter 2020, Five Prime Therapeutics Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Five Prime Therapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the fourth quarter 2020.


FPRX Net Income ( Y/Y Growth %) 2020
 2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Five Prime Therapeutics Inc 's fourth quarter 2020 Net Income $ -20.85 millions FPRX's Income Statement
Five Prime Therapeutics Inc 's fourth quarter 2019 Net Income $ -31.36 millions Quarterly FPRX's Income Statement
New: More FPRX's historic Net Income Growth >>


FPRX Net Income (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -


Compare FPRX Profitability >> Back to FPRX Growth rate Comparisons >>


Net Income fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Five Prime Therapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FPRX's IV. Quarter Q/Q Net Income Comment
Despite the fact, that Five Prime Therapeutics Inc in the IV. Quarter 2020 revealed net loss of $ -20.85 millions, it should be said, that current results point to recovery compare to the -26.42 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Five Prime Therapeutics Inc achieved highest sequential Net Income growth. While Five Prime Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FPRX's IV. Quarter Q/Q Net Income Comment
Even if Five Prime Therapeutics Inc in the IV. Quarter 2020 revealed net loss of $ -20.85 millions, it should be mentioned, that this point to improvement in contrast to the -26.42 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Five Prime Therapeutics Inc achieved highest sequential Net Income growth. While Five Prime Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Five Prime Therapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)
Cumulative Net Income 12 Months Ending $ -84.33 $ -94.83 $ -104.48 $ -121.93 $ -137.20
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #

New: More FPRX's historic Net Income Growth >>



Cumulative Net Income growth Comment


Five Prime Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Five Prime Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
FPRX's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for FPRX's Competitors
Net Income Growth for Five Prime Therapeutics Inc 's Suppliers
Net Income Growth for FPRX's Customers

You may also want to know
FPRX's Annual Growth Rates FPRX's Profitability Ratios FPRX's Asset Turnover Ratio FPRX's Dividend Growth
FPRX's Roe FPRX's Valuation Ratios FPRX's Financial Strength Ratios FPRX's Dividend Payout Ratio
FPRX's Roa FPRX's Inventory Turnover Ratio FPRX's Growth Rates FPRX's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2020
Fresenius Medical Care Ag-0.19%$ -0.185 millions
Enovis Corporation-0.86%$ -0.860 millions
Sensus Healthcare Inc -1.99%$ -1.991 millions
Xeris Biopharma Holdings Inc -2.78%$ -2.784 millions
Dr Reddy s Laboratories Limited-4.78%$ -4.779 millions
Amgen Inc -5.17%$ -5.167 millions
National Research Corporation-5.59%$ -5.587 millions
Fonar Corporation-6.68%$ -6.676 millions
Zoetis Inc -6.77%$ -6.771 millions
Supernus Pharmaceuticals inc -7.13%$ -7.127 millions
Ironwood Pharmaceuticals inc -9.72%$ -9.725 millions
Abiomed Inc -10.62%$ -10.617 millions
Lifevantage Corp-11.41%$ -11.411 millions
Icon Plc-11.41%$ -11.412 millions
Corcept Therapeutics Inc-11.53%$ -11.528 millions
Taro Pharmaceutical Industries Ltd-13.32%$ -13.318 millions
Radnet Inc -13.37%$ -13.369 millions
Carlisle Companies Incorporated-21.44%$ -21.442 millions
Stryker Corp-21.66%$ -21.655 millions
Utah Medical Products Inc-21.71%$ -21.707 millions
Davita Inc -22.64%$ -22.640 millions
Kamada Ltd -22.97%$ -22.970 millions
Ufp Technologies Inc -27.78%$ -27.783 millions
Amarin Corp Plcuk-30.31%$ -30.306 millions
Novartis Ag-31.23%$ -31.235 millions
Pra Health Sciences Inc -31.48%$ -31.476 millions
Springworks Therapeutics Inc -33.04%$ -33.036 millions
Pacific Health Care Organization Inc -35.40%$ -35.397 millions
Concert Pharmaceuticals Inc -37.70%$ -37.699 millions
Zynex inc -39.36%$ -39.362 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com